Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Oppenheimer Analyst Maintains Positive Outlook on Clarivate with Revised Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
SO stock news
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Oppenheimer analyst Owen Lau reaffirms his positive outlook on Clarivate (NYSE:CLVT) with an “Outperform” rating, but has revised the price target down to $10 from $11. This adjustment follows a previous update where the price target was increased from $10 to $11. Analysts have consistently rated Clarivate as “Outperform,” with price targets ranging from $10 to $15. Oppenheimer’s stock recommendations and price targets are highly regarded in the market, offering valuable guidance for investors.

CLVT Stock Plummets 17.45% in One Day: Investors Keep a Close Eye

On February 28, 2024, CLVT stock experienced a significant drop in its price performance. According to CNN Money, the stock closed at $7.38, which marked a decrease of $1.56 or 17.45% since the previous market close. Despite the negative performance during regular trading hours, there was a slight uptick in after-hours trading, with the stock rising $0.06. Investors and analysts will likely be monitoring the stock closely in the coming days to see if this drop in price is indicative of a larger trend or if it was a temporary fluctuation. It will be important to consider any relevant news or developments that may have contributed to the stock’s performance on this particular day.

CLVT Stock Performance Analysis: Mixed Results on February 28, 2024

On February 28, 2024, CLVT stock had mixed performances based on the financial data provided by CNN Money. The total revenue for the company stood at $2.63 billion for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter was $683.70 million, also holding flat compared to the previous quarter.

The net income for CLVT showed contrasting trends. The net income for the past year was reported at -$911.20 million, which represented a 76.99% increase compared to the previous year. On the other hand, the net income for the fourth quarter was reported at -$843.90 million, indicating a significant decrease of 6960.98% compared to the previous quarter.

Earnings per share (EPS) for CLVT also displayed divergent trends. The EPS for the past year was reported at -$1.47, showing a 76.45% increase compared to the previous year. However, the EPS for the fourth quarter was reported at -$1.30, indicating a substantial decrease of 13141.84% compared to the previous quarter.

Overall, the financial performance of CLVT on February 28, 2024, showcased a mix of positive and negative indicators. Investors and analysts would need to closely monitor these financial metrics to assess the future prospects of CLVT stock.

Tags: CLVT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investings on laptop and finances

Title Payoneer Global Remains Optimistic Despite Revenue Projection Dip

Empowering Beauty The Mission of Purple Boudoir

Pharmaceutical Markets and money

Mixed Results from PL9643 MELODY1 Phase 3 Clinical Trial for Dry Eye Disease

Recommended

Co-Diagnostics Stock

Co-Diagnostics Shares Plummet Following Dilutive Financing Move

5 months ago
Biotechnology Stock Market Today (1)

The Rise of OpenSource AI AbacusAIs Smaug72B Surpasses GPT35

2 years ago
Western Digital Stock

Western Digital Shares Maintain Extraordinary Rally

4 months ago
Precision BioSciences Inc Stock

Precision BioSciences Stock Surges on Gene-Editing Breakthroughs

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Copper’s Critical Role Powers Freeport-McMoRan’s Strategic Expansion

Western Digital’s Strategic Pivot Secures Dominance in Data Storage

Intuit Doubles Down on Share Buybacks Amid Market Pressure

Strategic Alliance Strengthens US Critical Minerals Independence

Zscaler’s Upward Revision: Security Demand in the AI Era Fuels Optimism

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

Trending

Atlassian Stock
AI & Quantum Computing

Atlassian Shares Hit Fresh Annual Low Amid Sector-Wide Concerns

by Jackson Burston
March 25, 2026
0

Atlassian stock touched a new 52-week low in today's trading session, declining by approximately eight percent. This...

Johnson & Johnson Stock

Institutional Investors Increase Stakes in Healthcare Giant Johnson & Johnson

March 25, 2026
Qualcomm Stock

Qualcomm Launches Major Capital Return Initiative Amid Strategic Shift

March 25, 2026
Freeport-McMoRan Stock

Copper’s Critical Role Powers Freeport-McMoRan’s Strategic Expansion

March 25, 2026
Western Digital Stock

Western Digital’s Strategic Pivot Secures Dominance in Data Storage

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Atlassian Shares Hit Fresh Annual Low Amid Sector-Wide Concerns
  • Institutional Investors Increase Stakes in Healthcare Giant Johnson & Johnson
  • Qualcomm Launches Major Capital Return Initiative Amid Strategic Shift

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com